Keywords: Novartis, 4th qtr and full year 2009, Financial results, Senior mangement

Novartis posts 50% 4th-qtr 2009 profits rise and promotes drugs chief Jimenez to CEO; other top changes

Article | 26 January 2010

Swiss drugmaker Novartis this morning said that it had achieved record results in 2009 as momentum from recently-launched products drove growth ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Sandoz

Alcon

Astra Zeneca

AstraZeneca

Go to company listing

Related Drugs

Valsartan

Diovan

Ranibizumab Injection

Letrozole

Femara

Go to drug listing